Illustration of blood vessels being repaired in a leg.

Shorter Healing Times: Can Planned Procedures Help With Critical Limb Ischemia?

"Discover how a new approach to endovascular therapy is improving recovery for patients with severe leg problems."


Critical limb ischemia (CLI), the most severe form of peripheral artery disease, poses a significant threat to those affected. In CLI, reduced blood flow to the limbs leads to pain, sores that don't heal, and potentially amputation. Endovascular treatment (EVT), a minimally invasive procedure to restore blood flow, has become a standard approach. However, the journey to recovery can be long and challenging, often requiring multiple EVT procedures.

A common problem is that wounds may take a long time to heal, leading to prolonged discomfort and delayed rehabilitation. Traditionally, target lesion revascularization (TLR) – repeat interventions to open blocked arteries – are performed when wound healing stalls or when tests indicate reduced blood flow. This reactive approach may inadvertently extend the healing process.

Now, a new study investigates whether a planned, proactive approach to EVT can shorten the time to wound healing in CLI patients with tissue loss. Instead of waiting for problems to arise, regular TLR procedures are scheduled. This article explores the findings of this research, offering insights into how planned EVT could become a valuable strategy for improving outcomes for CLI patients.

AI Search Multiple angles on this topic

How Limb-Salvage Treatment Evolved

Critical limb ischemia (CLI) was first defined in 1982 to identify patients with a threatened lower extremity primarily due to chronic ischemia. Endovascular therapy has been used for CLI for approximately four decades, although supporting data have been studied more recently. Over the past decade, the first-line approach to limb salvage has shifted from bypass surgery toward endovascular intervention; studies described in a 2016 chapter generally supported outcomes equivalent to surgery.

Planned vs. Reactive EVT: What's the Difference?

Illustration of blood vessels being repaired in a leg.

The study, conducted at Morinomiya Hospital in Osaka, Japan, compared two approaches to EVT in patients with CLI and tissue loss. The first group received conventional EVT, where repeat procedures were performed based on signs of delayed wound healing or decreased blood flow to the affected area. The second group underwent planned EVT, where TLR procedures were scheduled every two months, regardless of immediate signs of problems.

Researchers analyzed the outcomes of 89 limbs in 76 patients who had undergone at least two EVT procedures. The conventional EVT group included 52 limbs treated between January 2013 and December 2015, while the planned EVT group consisted of 37 limbs treated between January 2016 and October 2016.

  • Conventional EVT (Reactive): TLR performed only when wound healing slowed or blood flow decreased.
  • Planned EVT (Proactive): TLR scheduled every two months, regardless of immediate symptoms.
AI Search Multiple angles on this topic

Recent Studies Highlight Wound Care and Follow-Up

Recent research includes a study of endovascular therapy outcomes in renal transplant recipients with chronic limb-threatening ischemia (CLTI), which defines procedural success using a residual angiographic diameter stenosis threshold of 30%. A multicenter comparative study of endovascular treatment alone versus treatment plus Rheocarna hypothesizes that early combination therapy with revascularization may have potential utility before deep vein arterialization, while noting that its role remains unclear. A separate report on skin perfusion pressure after endovascular therapy emphasizes proper wound care and meticulous follow-up as important to achieving wound healing.

Successful Revascularization May Not Heal Every Wound

A report on planned endovascular therapy for CLI patients with tissue loss notes that revascularization was technically successful in some patients whose wounds still did not completely heal. This finding shows that procedural success alone does not guarantee complete wound healing. The report’s observation concerns patients with tissue loss and does not establish how often this outcome occurs more broadly.

Comparing Endovascular and Surgical Revascularization

The BEST-CLI study was designed to compare surgical and endovascular treatment in adults with CLTI who were eligible for either option. A 2022 cohort study compared six-month outcomes between endovascular and surgical revascularization strategies among propensity score–matched patients with CLI. A 2025 meta-analysis of 14 randomized trials reported greater technical success and one-year primary patency with bypass surgery, alongside increased 30-day morbidity and mortality and a higher one-year major amputation rate. These sources address different populations and outcomes, so the comparison does not establish a single approach as superior in every respect.

The key question was whether the planned EVT strategy could lead to faster wound healing compared to the conventional approach. The study also looked at the overall success rate of wound healing in both groups.

The Bottom Line: Is Planned EVT a Better Approach?

The study results suggest that planned EVT can significantly shorten the time to wound healing in CLI patients with tissue loss. While the overall wound healing rates were similar between the two groups (around 70%), the planned EVT group experienced significantly faster recovery times (95 days vs. 143 days).

AI Search Multiple angles on this topic

Randomized Evidence and Performance Benchmarks

The BEST-CLI and BASIL-2 studies provide randomized data intended to inform evidence-based decisions about treatment for CLTI. The supplied summary reports that BEST-CLI concluded surgical bypass was superior to endovascular intervention, but does not specify the comparison’s outcome or the population details. Separately, the Society for Vascular Surgery created Objective Performance Goals (OPGs) for CLI in 2009; the stated benchmarks for peripheral interventions are below 8% for major adverse cardiac events, below 8% for major adverse limb events, and below 3% for major amputation.

Access to Revascularization and the Broader CLI Burden

Critical limb ischemia is described as a severe manifestation of peripheral arterial disease, marked by rest pain, non-healing ulcers, and high risk of limb loss. A 2011 review suggested that endovascular therapy’s favorable risk-benefit profile could allow revascularization to be offered to a broader spectrum of patients and might improve limb-salvage rates across the CLI population. Another review describes revascularization as the cornerstone of CLI treatment while characterizing the field as an active focus of medical research. A supplied two-year study summary reports that it evaluated endovascular interventions in 150 patients, examining limb salvage, vascular patency, and reintervention needs.

This finding suggests that a proactive approach to revascularization may prevent delays in wound healing and accelerate the recovery process. By scheduling regular TLR procedures, potential problems can be addressed early on, before they lead to stalled healing or further complications.

While the study has some limitations, including its retrospective nature and relatively small sample size, the results offer promising evidence for the benefits of planned EVT in CLI management. Further research is needed to confirm these findings and explore the optimal protocols for planned EVT. However, this study provides valuable insights into how a proactive approach can improve outcomes for patients with this challenging condition.

A single-center comparison of planned and conventional EVT

PopulationCLI patients with tissue loss who underwent at least two EVTs[1]
Sample size76 patients; 89 limbs[1]
Settingsingle center[1]
Main outcomeTime to wound healing and complete wound healing rates[1]
Effect sizeTime to wound healing: 143 days in conventional group versus 95 days in planned group; complete wound healing rates: 71.2% versus 73.0%.[1]
p-valuep=0.025 for time to wound healing; p=1.0 for complete wound healing rate[1]
Times cited20[1]

How this result relates to other wound-healing evidence

A prospective registry reported a median healing time of 97 days after EVT and identified low body mass index and wound infection as risk factors for wounds that remained unhealed; it does not report a planned-versus-conventional comparison in the quoted finding.[2]

Another report found that some wounds remained unhealed even when at least one tibial artery had been successfully revascularized, underscoring that restored arterial flow and wound closure are distinct outcomes.[3]

What a follow-up study could clarify

  • Would a comparison across multiple centers reproduce the association between planned scheduling and shorter healing time?[4]
  • How much do wound severity, infection, recurrence, and wound-care practices contribute to healing time alongside the EVT schedule?[4]
  • Would the same pattern be observed with drug-coated balloons, which this study did not use?[4]

Terms used in the study

Skin perfusion pressure (SPP)
A measured pressure value used in this study to help determine when TLR was indicated.[1]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.5551/jat.45344, Alternate LINK

Title: Clinical Effects Of Planned Endovascular Therapy For Critical Limb Ischemia Patients With Tissue Loss

Subject: Biochemistry (medical)

Journal: Journal of Atherosclerosis and Thrombosis

Publisher: Japan Atherosclerosis Society

Authors: Masashi Fukunaga, Daizo Kawasaki, Machiko Nishimura, Masanao Yamagami, Reiko Fujiwara, Tsuyoshi Nakata

Published: 2019-03-01

Everything You Need To Know

1

What is Critical limb ischemia (CLI), and why is it so important?

Critical limb ischemia (CLI) is the most severe form of peripheral artery disease. It results from reduced blood flow to the limbs, causing pain, non-healing sores, and the risk of amputation. CLI's significance lies in its potential to cause severe complications. The implications for patients are significant, including chronic pain, reduced mobility, and a diminished quality of life. Without proper intervention, CLI can lead to limb loss.

2

What is Endovascular treatment (EVT), and why is it used?

Endovascular treatment (EVT) is a minimally invasive procedure designed to restore blood flow to the limbs in patients with Critical limb ischemia (CLI). It is considered a standard approach for treating CLI. EVT's importance stems from its ability to address the underlying cause of CLI by improving blood circulation. EVT offers a less invasive alternative to traditional surgery, potentially leading to quicker recovery times and reduced complications. However, the recovery journey can still be lengthy and may involve multiple procedures.

3

What is Target lesion revascularization (TLR), and how is it used in treatment?

Target lesion revascularization (TLR) refers to repeat interventions aimed at opening blocked arteries. Its use in the context of Endovascular treatment (EVT) is crucial. Traditionally, TLR has been performed reactively, that is, when wound healing stalls, or tests reveal reduced blood flow. The implications of TLR are significant, affecting healing times and the overall recovery process. This reactive approach, however, may inadvertently prolong the healing process, delaying a return to normal life.

4

What is planned Endovascular treatment (EVT), and why is it considered beneficial?

Planned Endovascular treatment (EVT) involves scheduling Target lesion revascularization (TLR) procedures proactively, typically every two months, regardless of immediate symptoms. This approach is contrasted with Conventional EVT where TLR is performed only when problems arise. The importance of planned EVT lies in its potential to shorten the time to wound healing. The implications for patients include a faster recovery, reduced discomfort, and a quicker return to daily activities. The study indicates that planned EVT can significantly improve outcomes for patients with Critical limb ischemia (CLI) and tissue loss.

5

What was compared in the study, and what were the implications of the findings?

The study compared Conventional Endovascular treatment (EVT) and planned EVT. Conventional EVT, or reactive EVT, involved performing Target lesion revascularization (TLR) when wound healing slowed or blood flow decreased. Planned EVT, or proactive EVT, scheduled TLR procedures every two months, irrespective of immediate symptoms. The study's findings suggest that planned EVT can significantly shorten the time to wound healing compared to conventional EVT. The implication is that this approach could become a valuable strategy for improving outcomes in patients with Critical limb ischemia (CLI) and tissue loss, leading to a better quality of life.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.